The global Next Generation Sequencing Technology market size was valued at US$ 5386 million in 2024 and is forecast to a readjusted size of USD 14210 million by 2031 with a CAGR of 15.0% during review period.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples. Next generation sequencing systems can be divided by three parts, instruments, consumables and related services. At the same time, NGS also supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection, and molecular analysis, which can drive discovery research and realize the bright future of personalized medicine.
The Next Generation Sequencing (NGS) Technology market is driven by the increasing demand for personalized medicine and advancements in genomic research. NGS technology enables rapid and high-throughput DNA and RNA sequencing, offering insights into genetic variations and molecular profiles for various applications in healthcare and life sciences. The rise in genetic diseases and cancer cases contributes to market growth as researchers and clinicians seek comprehensive genetic information for diagnosis, treatment, and drug development. Moreover, technological innovations in sequencing platforms and data analysis align with improved accuracy, speed, and cost-effectiveness of sequencing processes. However, the market also faces challenges, including managing and interpreting large volumes of genomic data and addressing ethical and privacy concerns related to genetic information. Additionally, ensuring standardization and quality control in NGS workflows and navigating regulatory requirements can pose obstacles for stakeholders. To succeed, companies must focus on data analytics solutions, collaborations in multi-omics research, and addressing the challenges to meet the increasing demand for NGS technology that drives advancements in personalized medicine and genomics research.
This report is a detailed and comprehensive analysis for global Next Generation Sequencing Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Next Generation Sequencing Technology market size and forecasts, in consumption value ($ Million), 2020-2031
Global Next Generation Sequencing Technology market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Next Generation Sequencing Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Next Generation Sequencing Technology market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next Generation Sequencing Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next Generation Sequencing Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Next Generation Sequencing Technology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Market segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Market segment by players, this report covers
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Next Generation Sequencing Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next Generation Sequencing Technology, with revenue, gross margin, and global market share of Next Generation Sequencing Technology from 2020 to 2025.
Chapter 3, the Next Generation Sequencing Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Next Generation Sequencing Technology market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Sequencing Technology.
Chapter 13, to describe Next Generation Sequencing Technology research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next Generation Sequencing Technology by Type
1.3.1 Overview: Global Next Generation Sequencing Technology Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Next Generation Sequencing Technology Consumption Value Market Share by Type in 2024
1.3.3 Targeted Sequencing
1.3.4 Whole Exome Sequencing
1.3.5 Whole Genome Sequencing
1.4 Global Next Generation Sequencing Technology Market by Application
1.4.1 Overview: Global Next Generation Sequencing Technology Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Clinics
1.4.3 Biopharma Companies
1.4.4 Academic & Research Organizations
1.4.5 Others
1.5 Global Next Generation Sequencing Technology Market Size & Forecast
1.6 Global Next Generation Sequencing Technology Market Size and Forecast by Region
1.6.1 Global Next Generation Sequencing Technology Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Next Generation Sequencing Technology Market Size by Region, (2020-2031)
1.6.3 North America Next Generation Sequencing Technology Market Size and Prospect (2020-2031)
1.6.4 Europe Next Generation Sequencing Technology Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Next Generation Sequencing Technology Market Size and Prospect (2020-2031)
1.6.6 South America Next Generation Sequencing Technology Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Next Generation Sequencing Technology Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Eurofins Scientific
2.1.1 Eurofins Scientific Details
2.1.2 Eurofins Scientific Major Business
2.1.3 Eurofins Scientific Next Generation Sequencing Technology Product and Solutions
2.1.4 Eurofins Scientific Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Eurofins Scientific Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera Next Generation Sequencing Technology Product and Solutions
2.2.4 Natera Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Natera Recent Developments and Future Plans
2.3 BGI
2.3.1 BGI Details
2.3.2 BGI Major Business
2.3.3 BGI Next Generation Sequencing Technology Product and Solutions
2.3.4 BGI Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 BGI Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Next Generation Sequencing Technology Product and Solutions
2.4.4 Illumina Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Next Generation Sequencing Technology Product and Solutions
2.5.4 Roche Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Roche Recent Developments and Future Plans
2.6 LabCorp
2.6.1 LabCorp Details
2.6.2 LabCorp Major Business
2.6.3 LabCorp Next Generation Sequencing Technology Product and Solutions
2.6.4 LabCorp Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LabCorp Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics Next Generation Sequencing Technology Product and Solutions
2.7.4 Berry Genomics Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Brooks Life Sciences
2.8.1 Brooks Life Sciences Details
2.8.2 Brooks Life Sciences Major Business
2.8.3 Brooks Life Sciences Next Generation Sequencing Technology Product and Solutions
2.8.4 Brooks Life Sciences Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Brooks Life Sciences Recent Developments and Future Plans
2.9 Macrogen
2.9.1 Macrogen Details
2.9.2 Macrogen Major Business
2.9.3 Macrogen Next Generation Sequencing Technology Product and Solutions
2.9.4 Macrogen Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Macrogen Recent Developments and Future Plans
2.10 Personalis
2.10.1 Personalis Details
2.10.2 Personalis Major Business
2.10.3 Personalis Next Generation Sequencing Technology Product and Solutions
2.10.4 Personalis Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Personalis Recent Developments and Future Plans
2.11 Novogene
2.11.1 Novogene Details
2.11.2 Novogene Major Business
2.11.3 Novogene Next Generation Sequencing Technology Product and Solutions
2.11.4 Novogene Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Novogene Recent Developments and Future Plans
2.12 Genotypic Technology
2.12.1 Genotypic Technology Details
2.12.2 Genotypic Technology Major Business
2.12.3 Genotypic Technology Next Generation Sequencing Technology Product and Solutions
2.12.4 Genotypic Technology Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Genotypic Technology Recent Developments and Future Plans
2.13 Dna Link
2.13.1 Dna Link Details
2.13.2 Dna Link Major Business
2.13.3 Dna Link Next Generation Sequencing Technology Product and Solutions
2.13.4 Dna Link Next Generation Sequencing Technology Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Dna Link Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Next Generation Sequencing Technology Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Next Generation Sequencing Technology by Company Revenue
3.2.2 Top 3 Next Generation Sequencing Technology Players Market Share in 2024
3.2.3 Top 6 Next Generation Sequencing Technology Players Market Share in 2024
3.3 Next Generation Sequencing Technology Market: Overall Company Footprint Analysis
3.3.1 Next Generation Sequencing Technology Market: Region Footprint
3.3.2 Next Generation Sequencing Technology Market: Company Product Type Footprint
3.3.3 Next Generation Sequencing Technology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Next Generation Sequencing Technology Consumption Value and Market Share by Type (2020-2025)
4.2 Global Next Generation Sequencing Technology Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Next Generation Sequencing Technology Consumption Value Market Share by Application (2020-2025)
5.2 Global Next Generation Sequencing Technology Market Forecast by Application (2026-2031)
6 North America
6.1 North America Next Generation Sequencing Technology Consumption Value by Type (2020-2031)
6.2 North America Next Generation Sequencing Technology Market Size by Application (2020-2031)
6.3 North America Next Generation Sequencing Technology Market Size by Country
6.3.1 North America Next Generation Sequencing Technology Consumption Value by Country (2020-2031)
6.3.2 United States Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
6.3.3 Canada Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
6.3.4 Mexico Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Next Generation Sequencing Technology Consumption Value by Type (2020-2031)
7.2 Europe Next Generation Sequencing Technology Consumption Value by Application (2020-2031)
7.3 Europe Next Generation Sequencing Technology Market Size by Country
7.3.1 Europe Next Generation Sequencing Technology Consumption Value by Country (2020-2031)
7.3.2 Germany Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
7.3.3 France Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
7.3.5 Russia Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
7.3.6 Italy Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing Technology Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Next Generation Sequencing Technology Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Next Generation Sequencing Technology Market Size by Region
8.3.1 Asia-Pacific Next Generation Sequencing Technology Consumption Value by Region (2020-2031)
8.3.2 China Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
8.3.3 Japan Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
8.3.4 South Korea Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
8.3.5 India Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
8.3.7 Australia Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
9 South America
9.1 South America Next Generation Sequencing Technology Consumption Value by Type (2020-2031)
9.2 South America Next Generation Sequencing Technology Consumption Value by Application (2020-2031)
9.3 South America Next Generation Sequencing Technology Market Size by Country
9.3.1 South America Next Generation Sequencing Technology Consumption Value by Country (2020-2031)
9.3.2 Brazil Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
9.3.3 Argentina Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing Technology Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Next Generation Sequencing Technology Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Next Generation Sequencing Technology Market Size by Country
10.3.1 Middle East & Africa Next Generation Sequencing Technology Consumption Value by Country (2020-2031)
10.3.2 Turkey Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
10.3.4 UAE Next Generation Sequencing Technology Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Next Generation Sequencing Technology Market Drivers
11.2 Next Generation Sequencing Technology Market Restraints
11.3 Next Generation Sequencing Technology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Next Generation Sequencing Technology Industry Chain
12.2 Next Generation Sequencing Technology Upstream Analysis
12.3 Next Generation Sequencing Technology Midstream Analysis
12.4 Next Generation Sequencing Technology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
听
听
*If Applicable.
